I've pleaded with my insurance company and even the pharmacy to help me out in this same situation. They have been adamant that there is only one exception to their rules against PDE5 inhibitors being covered. A letter from my doctor was not of interest to them. The exception is for BPH, when at least two other meds have failed. Because I don't have a prostate any more, it's hard to argue that I have BPH.
I am in the process of getting a new written script
from my doctor. I will then fax it to a Canadian pharmacy, and my order will be transferred to India. I will then get a full year's supply of generic tadafalil for about
$200 plus shipping. This is about
what I am paying per month out of pocket in the US.
Generic Viagra will be allowed in the US in 2017, under an agreement that allows the patent to otherwise stay in place until 2020.
The best hope for lower prices in the US will be when Viagra is finally off patent, which may force the manufacturers of other PDE5 inhibitors to lower their prices somewhat to compete with the generic Viagra.
In the interim, I'm going to use the Canadian pharmacy (Cialis is still under patent there) to get the generic drug from India. It really sucks that something called "insurance" is really nothing of the kind - just a cold-hearted profit center.
edit: Replaced "Cialis" with "Viagra" in line about
Age 51 at Dx, 52 now
8/13 PSA 5.0
9/13 PSA 5.3 after DRE
10/13 PSA 4.9
10/13 - Biopsy - Gleason 3+4, 4 samples of 12 positive, 3 were 3+3, 1 was 3+4
1/6/2014 - RALP
Post-surgical pathology: pT2cNx Gleason 3+4=7 disease, neg margins
1/14/2014 - Catheter removed
2/6/2014 - Started on TriMix
4/14/2014, 7/14/2014 - PSA undetectable
Resumed TRT on 7/22 (used for 15 months before diagnosis)
Post Edited (dmlvt) : 9/12/2014 1:42:43 PM (GMT-6)